affect
lung
show
sever
consolid
tissu
consist
approxim
liver
fig
sar
lung
averag
three
four
time
heavier
normal
lung
convent
light
microscopi
lm
demonstr
widespread
damag
lung
parenchyma
extens
fibrin
exud
edema
interstiti
thicken
extens
hyalin
membran
format
fig
b
extens
alveolar
collaps
remain
alveoli
fill
fluid
desquam
alveolar
bronchial
epitheli
cell
alveolar
epitheli
hyperplasia
evid
larg
syncyti
cell
multipl
nuclei
present
small
vessel
vascul
seen
howev
cellular
infiltr
rare
conspicu
absent
case
lymphocyt
infiltr
spars
overal
diffus
alveolar
damag
resembl
seen
adult
respiratori
distress
syndrom
pauciti
inflammatori
infiltr
situ
hybrid
demonstr
sar
viral
sequenc
cytoplasm
larg
number
intact
degener
epitheli
cell
lung
well
scanti
infiltr
lymphocyt
cluster
macrophag
fig
c
pulmonari
epitheli
cell
identifi
immunostain
use
antibodi
giant
syncyti
cell
particularli
rich
hybrid
signal
monocyt
lymphocyt
blood
vessel
lung
also
posit
situ
hybrid
fig
e
neg
control
situ
hybrid
sar
genom
sequenc
lung
show
posit
signal
unrel
probe
use
fig
f
em
demonstr
sarslik
viral
particl
cytoplasm
epitheli
cell
fig
h
situ
hybrid
specif
probe
colloid
goldlabel
secondari
antibodi
detect
specif
posit
signal
cytoplasm
epitheli
cell
type
ii
em
level
fig
g
doubl
label
sarsinfect
cell
situ
hybrid
cytokeratin
immunolabel
reveal
pulmonari
epitheli
cell
infect
sar
viru
prolif
cell
lung
mainli
type
ii
cell
evidenc
lm
morpholog
sar
viral
sequenc
also
detect
epitheli
cell
trachea
bronchi
bronchiol
situ
hybrid
fig
j
ciliat
epitheli
cell
trachea
display
posit
cytoplasm
situ
hybrid
posit
signal
detect
neg
control
unrel
probe
use
k
among
sar
blood
sampl
obtain
earli
stage
diseas
em
detect
sarslik
viral
particl
monocyt
lymphocyt
six
patient
round
viral
particl
diamet
nm
locat
cytoplasm
particl
doubl
membran
pale
core
short
process
project
outward
percentag
total
circul
lymphocyt
decreas
tabl
percentag
differ
cell
type
harbor
sarslik
viral
particl
shown
tabl
ii
posit
sampl
includ
taken
within
onset
fever
one
instanc
earli
infect
cell
cell
b
cell
nk
cell
also
infect
viru
em
viral
particl
tend
form
cluster
locat
within
near
endoplasm
reticulum
lymphocyt
identifi
uniqu
morpholog
size
diamet
round
shape
irregular
cell
membran
small
villou
process
larg
round
sometim
irregular
nucleu
small
quantiti
cytoplasm
devoid
lysosom
label
cell
antibodi
preembed
immunoperoxidas
label
em
confirm
natur
cell
macrophag
appear
activ
becam
slightli
larger
natur
cell
confirm
immunohistochemistri
autopsi
sampl
situ
hybrid
em
demonstr
virusinfect
immun
cell
circul
blood
spleen
lymph
node
lymphoid
tissu
variou
organ
larg
proport
lymphocyt
circul
lymphoid
organ
contain
viru
fig
b
spleen
lymph
node
atroph
fig
l
averag
weight
spleen
control
unconfirm
case
lm
hematoxylin
eosin
stain
reveal
notabl
decreas
lymphocyt
organ
fig
c
immunolabel
seven
marker
undertaken
identifi
seven
cell
type
tabl
iii
immun
cell
type
includ
dendrit
cell
decreas
significantli
p
posit
macrophag
decreas
number
notic
p
increas
size
gave
impress
macrophag
activ
fig
e
neg
control
immunohistochemistri
spleen
confirm
sar
patient
pb
substitut
antibodi
posit
signal
detect
fig
f
situ
hybrid
identifi
sar
viral
sequenc
enlarg
macrophag
isol
sometim
cluster
lymphocyt
distribut
mostli
peripheri
germin
center
splenic
white
pulp
lymph
node
peripher
blood
fig
e
fig
g
h
j
lymphoid
compon
intestin
show
widespread
degen
chang
lymphoid
follicl
peyer
patch
show
markedli
decreas
lymphocyt
fig
sever
case
deplet
stromal
framework
structur
remain
em
detect
viral
particl
submucosa
gut
fig
b
c
within
residu
lymphocyt
situ
hybrid
demonstr
presenc
sar
posit
lymphocyt
mucosa
submucosa
fig
posit
signal
found
neg
control
specif
probe
use
nonsar
case
fig
e
f
confirm
sar
case
digest
tract
display
mild
inflammatori
chang
obviou
lesion
digest
tract
deplet
submucosa
lymphoid
tissu
describ
fig
addit
epitheli
cell
mucosa
small
larg
intestin
found
infect
viru
situ
hybrid
em
fig
g
similar
posit
cell
found
stomach
esophagu
detail
descript
gastrointestin
involv
sar
report
separ
posit
reaction
seen
neg
specif
probe
nonsar
case
fig
h
kidney
focal
hemorrhag
situ
hybrid
local
viral
sequenc
epitheli
cell
renal
distal
tubul
fig
j
cluster
sar
viral
particl
also
detect
cytoplasm
distal
tubular
epithelium
em
fig
n
specif
reaction
establish
neg
control
fig
k
l
sar
genom
sequenc
detect
brain
sar
autopsi
lm
em
realtim
rtpcr
signal
confin
cytoplasm
numer
neuron
hypothalamu
cortex
fig
edema
scatter
red
degener
neuron
present
brain
six
eight
confirm
case
sar
sar
viral
sequenc
patholog
chang
present
brain
unconfirm
case
control
case
fig
p
q
five
eight
confirm
case
hepatocyt
centrilobular
zone
show
appar
degen
chang
test
seven
male
patient
display
focal
atrophi
howev
sar
viral
sequenc
viral
particl
identifi
parenchym
cell
situ
hybrid
em
organ
obviou
patholog
chang
observ
heart
pancrea
adren
gland
thyroid
gland
skelet
muscl
although
sarsharbor
lymphocyt
monocyt
found
organ
mostli
within
vessel
tissu
sampl
mouth
nasal
mucosa
bone
marrow
avail
examin
retrospect
analys
reveal
signific
differ
lymphocyt
subtyp
blood
sampl
collect
differ
time
point
onset
diseas
confirm
sar
patient
versu
misdiagnos
case
p
fig
lymphocyt
cell
decreas
onset
symptom
decreas
persist
recoveri
phase
glucocorticoid
administ
lymphocyt
decreas
group
patient
howev
differ
lymphocyt
count
sar
nonsar
case
persist
differ
blood
cell
type
patient
signific
shown
confirm
sar
case
similar
patholog
chang
lung
lymphoid
organ
differ
sever
sever
damag
immun
system
extent
pulmonari
damag
fibrosi
correspond
durat
diseas
count
onset
symptom
contrast
suspect
unconfirm
case
demonstr
wide
rang
patholog
vari
etiolog
case
three
case
patholog
chang
lung
similar
seen
confirm
case
sar
howev
edema
consolid
hyalin
membran
format
fibrosi
less
promin
damag
pulmonari
epitheli
cell
multipl
organ
infect
characterist
featur
confirm
case
sar
patient
damag
immun
system
found
patient
sar
patient
similar
symptom
harbor
viru
neuron
chang
demonstr
sar
viru
infect
uniqu
patient
sar
found
misdiagnos
case
control
use
sar
assay
neg
therebi
establish
specif
situ
hybrid
immunohistochemistri
procedur
addit
control
includ
doubl
label
exclud
possibl
interfer
situ
hybrid
immunohistochem
reaction
perform
combin
base
find
propos
follow
pathogenesi
mechan
sar
sar
viru
enter
bodi
respiratori
tract
first
infect
epitheli
cell
trachea
bronchi
bronchiol
lung
viru
infect
resid
infiltr
circul
immun
cell
circul
immun
cell
carri
viru
organ
viru
infect
damag
immun
cell
spleen
peripher
central
lymph
node
lymphoid
tissu
immun
defens
weaken
significantli
lead
rapid
deterior
pneumonia
manner
bloodborn
sar
viru
infect
organ
patient
compromis
immun
function
chronic
diseas
age
individu
suffer
sever
ill
much
higher
mortal
sar
extent
immun
cell
damag
reflect
lymphocyt
count
manifest
patient
immun
statu
predictor
outcom
damag
immun
system
damag
lung
determin
whether
patient
recov
die
infect
way
name
sudden
acut
respiratori
syndrom
inappropri
divert
attent
primari
patholog
chang
result
sar
viru
infect
must
emphas
immun
damag
like
primari
determin
clinic
outcom
studi
unveil
hitherto
unknown
signific
aspect
pathogenesi
sar
propos
mechan
infect
dissemin
capabl
explain
clinic
symptom
laboratori
find
report
sar
provid
comprehens
theori
pathogenesi
new
diseas
way
sar
infect
similar
hiv
infect
caus
aid
although
hiv
attack
destroy
target
cell
slowli
particularli
lymphocyt
sar
viru
infect
destroy
immun
cell
much
faster
devast
fashion
like
mani
infecti
diseas
sar
infect
show
differ
degre
sever
differ
individu
sever
case
demonstr
full
rang
patholog
chang
describ
find
suggest
bodi
fluid
tract
transmiss
viru
although
report
possibl
sar
virus
sequenc
detect
blood
intestin
stool
urin
correct
understand
pathogenesi
crucial
develop
anim
model
test
effect
vaccin
establish
techniqu
earli
diagnosi
detail
studi
immun
damag
shed
light
true
natur
pathogenesi
sar
autopsi
perform
patient
suspect
die
sar
infect
die
june
august
confirm
sar
die
april
one
confirm
sar
world
health
organ
diagnost
criteria
sar
use
clinic
diagnos
includ
sar
contact
histori
sudden
onset
high
fever
respiratori
symptom
chest
xray
find
unrespons
antibiot
therapi
clinic
data
autopsi
case
present
tabl
iv
retrospect
analysi
suspect
sar
case
provid
comparison
true
misdiagnos
sar
case
confirm
sar
infect
made
realtim
rtpcr
demonstr
sar
sequenc
blood
tissu
sampl
sar
antibodi
posit
sera
patient
case
consid
repres
misdiagnosi
repeat
test
sarsspecif
antibodi
neg
case
test
least
twice
test
wk
apart
misdiagnosi
rate
one
hospit
patient
admit
hospit
sarslik
symptom
initi
period
sar
epidem
specif
antibodi
test
sar
genom
sequenc
detect
avail
confirm
misdiagnos
case
treat
similarli
confirm
case
sar
autopsi
tissu
sampl
agematch
otherwis
healthi
subject
die
head
trauma
serv
control
procedur
histopatholog
investig
autopsi
lm
em
perform
routin
laboratori
describ
previous
techniqu
situ
hybrid
base
zhang
et
al
brief
sequenc
bp
amplifi
polymeras
chain
reaction
sar
coronaviru
genom
sequenc
sequenc
data
avail
genbankemblddbj
access
rna
probe
prepar
vitro
transcript
presenc
digoxigeninutp
situ
hybrid
reaction
perform
formalinfix
paraffinembed
tissu
section
sar
probe
hybrid
cocktail
incub
h
alkalin
phosphataselabel
antidigoxigenin
antibodi
incub
min
color
achiev
nitroblu
phosphat
counterstain
methylgreen
immunoelectron
microscopi
base
techniqu
goldsmith
et
al
em
situ
hybrid
techniqu
base
vandel
et
al
brief
situ
hybrid
reaction
perform
tissu
grid
procedur
similar
lm
label
probe
detect
colloid
gold
nm
antibodi
digoxigenin
immunohistochemistri
perform
use
rang
monoclon
antibodi
identifi
differ
cell
type
infect
affect
viru
tabl
immunohistochemistri
perform
describ
lin
et
al
antigen
retriev
techniqu
perform
describ
previous
real
time
rtpcr
perform
techniqu
wu
et
al
brief
total
rna
extract
clinic
sampl
use
trizol
reagent
accord
manufactur
instruct
total
rna
transcrib
cdna
superscript
firststrand
cdna
synthesi
system
taqman
realtim
quantit
pcr
conduct
accord
manufactur
instruct
appli
biosystem
three
pair
primer
design
construct
genbank
design
primer
probe
use
realtim
pcr
situ
hybrid
describ
previous
innermost
pair
outer
pair
outermost
pair
molecular
beacon
techniqu
use
sensit
specif
standard
realtim
rtpcr
assay
detect
sarscov
postmortem
lung
tissu
establish
previous
identifi
cell
type
infect
viru
doubl
label
perform
combin
situ
hybrid
sar
viral
genom
sequenc
immunohistochemistri
one
cellassoci
marker
situ
hybrid
signal
visual
alkalin
phosphatas
result
dark
blue
color
wherea
posit
immunostain
signal
visual
diamenobenzodin
give
reddishbrown
color
two
signal
present
cell
stain
chang
purplish
color
easili
distinguish
either
primari
color
addit
situ
hybrid
immunohistochemistri
perform
separ
consecut
section
analyz
relationship
situ
hybrid
signal
immunostain
signal
ascertain
cell
type
infect
viru
seven
cell
marker
antigen
examin
identifi
epitheli
cell
macrophag
cell
b
cell
splenic
dendrit
cell
specif
sourc
antibodi
shown
tabl
iii
control
immunohistochemistri
includ
omiss
primari
antibodi
use
normal
mous
serum
place
primari
antibodi
control
situ
hybrid
includ
applic
unrel
probe
probe
ident
instead
complementari
sequenc
sar
genom
target
asid
control
describ
two
techniqu
addit
control
perform
doubl
stain
includ
situ
hybrid
immunostain
alon
ensur
one
reaction
interfer
diminish
enhanc
reaction
patholog
autopsi
case
repres
mid
late
stage
diseas
peripher
blood
sampl
taken
patient
confirm
sar
onset
high
fever
studi
rel
earli
chang
blood
sampl
patient
sar
examin
control
white
blood
cell
per
patient
examin
transmiss
electron
microscop
jeol
ii
oper
kw
addit
lymphocyt
count
patient
confirm
treat
steroid
glucocorticoid
patient
misdiagnos
treat
steroid
analyz
retrospect
identif
confirm
misdiagnos
case
achiev
sar
antibodi
test
describ
studi
approv
institut
scientif
ethic
committe
health
scienc
center
peke
univers
